Search results
It may be safe for some to wait 15 years for repeat colonoscopy, study suggests
NBC News via Yahoo News· 3 days agoNew research suggests average-risk patients may only need to get a colonoscopy for colorectal cancer...
CRC Screening in Primary Care: The Blood Test Option
Medscape· 2 weeks agoWill patients who are offered this option forego colonoscopy and instead opt for a blood test?
Tricare Lowers Age for Colon Cancer Screenings to 45
Military.com via Yahoo News· 5 days agoTricare beneficiaries at average risk for colorectal cancer can now receive covered screening exams and lab tests five years sooner, at age 45, following...
EFG Asset Management Americas Corp. Boosts Position in Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 2 weeks agoEFG Asset Management Americas Corp. boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 14.6% during the fourth quarter, according to the company in its most ...
Mutual of America Capital Management LLC Sells 350 Shares of Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 2 weeks agoMutual of America Capital Management LLC lowered its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 10.0% in the 4th quarter, according to the company in its most recent 13F filing ...
Van ECK Associates Corp Sells 9,078 Shares of Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 2 days agoVan ECK Associates Corp trimmed its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 6.1% in the 4th quarter, according to the company in its most recent Form 13F filing ...
Daiwa Securities Group Inc. Acquires 400 Shares of Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 1 week agoDaiwa Securities Group Inc. lifted its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities ...
Mackenzie Financial Corp Reduces Holdings in Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 1 week agoMackenzie Financial Corp cut its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 6.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange ...